Top Markets
Coin of the day
Skye Bioscience, Inc. Skye Bioscience, Inc.

Skye Bioscience, Inc.

SKYE
주식 순위 #31353
Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on... Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California.
주가
$0.4018
시가총액
$14.12M
변동 (1일)
-3.20%
변동 (1년)
-88.15%
국가
US
거래 Skye Bioscience, Inc. (SKYE)

카테고리

Skye Bioscience, Inc. (SKYE)의 주가 이력
최고 종가: $0.50 (2026-08-01 기준)

최저 종가: $2.50K (2014-11-01 기준)
Skye Bioscience, Inc.의 주가 이력 (2014 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) 27.56%
2025 -68.43%
2024 7.82%
2023 -19.28%
2022 -74.81%
2021 58.02%
2020 -81.19%
2019 -44.44%
2018 157.69%
2017 -64.63%
2016 -42.36%
2015 -92.76%
2014 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$532.21 36.51%
US
$1.00K 51.44%
NL
$111.31 -36.83%
AU
$735.86 6.87%
CH
$257.75 13.01%
BE